Celcuity (CELC) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $60.30, +0.67% vs the prior close of $59.90.
- Volume 2.12M shares, 2.0x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CELC rises 0.7% to $60.30 on 2.0x normal volume. Closed at $60.30, +0.67% vs the prior close of $59.90. Day range $60.00–$61.73, opened at $60.67.
CELC daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — CELC rises 0.7% to $60.30 on 2.0x normal volume
- Closed at $60.30, +0.67% vs the prior close of $59.90. Day range $60.00–$61.73, opened at $60.67.
- Volume was 2.12M shares, 2.0x its 50-day average of 1.05M — unusually heavy trading.
- Price is -27.9% vs its 50-day average ($83.62) and -41.4% vs its 200-day average ($102.86).
- 52-week range $46.51–$151.02; today's close sits at 13% of that range, 60.1% below the 52-week high.
Oct 14, 2026 — CELC slides 5.2% to $59.90, a 6-month low on 2.4x normal volume
- Closed at $59.90, -5.21% vs the prior close of $63.19. Day range $58.98–$63.44, opened at $62.60.
- Volume was 2.44M shares, 2.4x its 50-day average of 1.02M — unusually heavy trading.
- Price is -28.9% vs its 50-day average ($84.27) and -41.9% vs its 200-day average ($103.07).
- 52-week range $45.03–$151.02; today's close sits at 14% of that range, 60.3% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — CELC slides 4.0% to $63.19, a 6-month low
- Closed at $63.19, -4.04% vs the prior close of $65.85. Day range $62.86–$65.69, opened at $65.17.
- Volume was 1.50M shares, 1.5x its 50-day average of 1.00M.
- Price is -25.6% vs its 50-day average ($84.93) and -38.8% vs its 200-day average ($103.28).
- 52-week range $45.03–$151.02; today's close sits at 17% of that range, 58.2% below the 52-week high.
Oct 12, 2026 — CELC slides 3.1% to $65.85
- Closed at $65.85, -3.08% vs the prior close of $67.94. Day range $65.03–$67.52, opened at $67.40.
- Volume was 1.05M shares, 1.1x its 50-day average of 993.19K.
- Price is -22.9% vs its 50-day average ($85.42) and -36.4% vs its 200-day average ($103.47).
- 52-week range $45.03–$151.02; today's close sits at 20% of that range, 56.4% below the 52-week high.
Oct 9, 2026 — CELC ends flat (+0.1%) to $67.94
- Closed at $67.94, +0.10% vs the prior close of $67.87. Day range $66.91–$68.53, opened at $67.78.
- Volume was 1.28M shares, 1.3x its 50-day average of 994.09K.
- Price is -20.8% vs its 50-day average ($85.83) and -34.5% vs its 200-day average ($103.66).
- 52-week range $45.03–$151.02; today's close sits at 22% of that range, 55.0% below the 52-week high.
Oct 8, 2026 — CELC jumps 3.2% to $67.87 on 2.7x normal volume
- Closed at $67.87, +3.18% vs the prior close of $65.78. Day range $63.22–$69.08, opened at $64.74.
- Volume was 2.59M shares, 2.7x its 50-day average of 969.70K — unusually heavy trading.
- Price is -21.3% vs its 50-day average ($86.22) and -34.6% vs its 200-day average ($103.82).
- 52-week range $45.03–$151.02; today's close sits at 22% of that range, 55.1% below the 52-week high.
Oct 7, 2026 — CELC slides 7.7% to $65.78, a 6-month low on 3.3x normal volume
- Closed at $65.78, -7.68% vs the prior close of $71.25. Day range $64.15–$73.50, opened at $70.52.
- Volume was 3.16M shares, 3.3x its 50-day average of 945.82K — unusually heavy trading.
- Price is -24.0% vs its 50-day average ($86.53) and -36.7% vs its 200-day average ($103.99).
- 52-week range $45.03–$151.02; today's close sits at 20% of that range, 56.4% below the 52-week high.
Oct 6, 2026 — CELC slides 3.2% to $71.25, a 6-month low
- Closed at $71.25, -3.22% vs the prior close of $73.62. Day range $70.32–$76.29, opened at $74.28.
- Volume was 1.56M shares, 1.6x its 50-day average of 949.79K.
- Price is -18.0% vs its 50-day average ($86.86) and -31.6% vs its 200-day average ($104.16).
- 52-week range $45.03–$151.02; today's close sits at 25% of that range, 52.8% below the 52-week high.
Oct 5, 2026 — CELC rises 2.1% to $73.62 on 1.8x normal volume
- Closed at $73.62, +2.11% vs the prior close of $72.10. Day range $69.00–$74.60, opened at $72.71.
- Volume was 1.72M shares, 1.8x its 50-day average of 941.31K — unusually heavy trading.
- Price is -15.5% vs its 50-day average ($87.08) and -29.4% vs its 200-day average ($104.30).
- 52-week range $45.03–$151.02; today's close sits at 27% of that range, 51.3% below the 52-week high.
Oct 2, 2026 — CELC slides 4.0% to $72.10, a 6-month low
- Closed at $72.10, -4.03% vs the prior close of $75.13. Day range $70.68–$75.44, opened at $75.21.
- Volume was 1.42M shares, 1.5x its 50-day average of 947.93K.
- Price is -17.4% vs its 50-day average ($87.26) and -31.0% vs its 200-day average ($104.43).
- 52-week range $44.42–$151.02; today's close sits at 26% of that range, 52.3% below the 52-week high.
- SEC filings that day: 8-K.
CELC latest news & SEC filings
Every SEC filing by or about CELC in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 9, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Furcht Leo converted options/RSUs into 250 shares at $7.60 (≈$1.90K) on Oct 7, 2026; now holds 12,780
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 5, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Gryska David W received an award of 893 shares on Oct 1, 2026; now holds 893
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 5, 2026 · 3 — Initial insider ownership statement (Form 3)
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Oct 2, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 30, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Aug 26, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Aug 18, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 18, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 18, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 13, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$78.86M (prior year -$45.27M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$1.44 (prior year -$1.04) (loss widened vs Jun 30, 2025)
Aug 13, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 11, 2026 · SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 16, 2026 · SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 16, 2026 · SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 15, 2026 · 8-K/A — Amended current report
Amended current report
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Things to know before you trade CELC
- Last results release: Aug 13, 2026 (8-K Item 2.02). Previous ones: May 14, 2026, Mar 25, 2026, Nov 12, 2025. Based on that rhythm, the next report is likely around Nov 12, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.99% (largest 7.7%).
- Liquidity: about 1.48M shares (≈$89.31M) trade per day on average.
- 52-week position: $60.30 vs a range of $46.51–$151.02 (13% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 23 sales; latest: Julian Baker sold 2,838,632 shares on Jul 14, 2026.
- Latest filings: 8-K Oct 2, 2026; 8-K Sep 30, 2026; 8-K Aug 26, 2026.
- Share count: 48.93M shares outstanding (Aug 5, 2026), +15.3% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Services-Medical Laboratories.
CELC market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 60.67 | 61.73 | 60.00 | 60.30 | 2.12M |
| Oct 14, 2026 | 62.60 | 63.44 | 58.98 | 59.90 | 2.44M |
| Oct 13, 2026 | 65.17 | 65.69 | 62.86 | 63.19 | 1.50M |
| Oct 12, 2026 | 67.40 | 67.52 | 65.03 | 65.85 | 1.05M |
| Oct 9, 2026 | 67.78 | 68.53 | 66.91 | 67.94 | 1.28M |
| Oct 8, 2026 | 64.74 | 69.08 | 63.22 | 67.87 | 2.59M |
| Oct 7, 2026 | 70.52 | 73.50 | 64.15 | 65.78 | 3.16M |
| Oct 6, 2026 | 74.28 | 76.29 | 70.32 | 71.25 | 1.56M |
| Oct 5, 2026 | 72.71 | 74.60 | 69.00 | 73.62 | 1.72M |
| Oct 2, 2026 | 75.21 | 75.44 | 70.68 | 72.10 | 1.42M |
| Oct 1, 2026 | 78.38 | 79.18 | 75.00 | 75.13 | 1.10M |
| Sep 30, 2026 | 81.30 | 88.68 | 77.84 | 79.52 | 2.56M |
| Sep 29, 2026 | 79.64 | 80.52 | 77.25 | 77.38 | 1.22M |
| Sep 28, 2026 | 79.44 | 80.02 | 77.09 | 79.64 | 610.40K |
| Sep 25, 2026 | 80.00 | 80.28 | 78.02 | 79.52 | 657.20K |
| Sep 24, 2026 | 79.73 | 80.19 | 77.07 | 79.37 | 1.24M |
| Sep 23, 2026 | 84.93 | 85.05 | 79.40 | 79.99 | 739.30K |
| Sep 22, 2026 | 84.00 | 85.50 | 82.80 | 84.10 | 540.20K |
| Sep 21, 2026 | 81.37 | 84.33 | 80.26 | 84.00 | 718.10K |
| Sep 18, 2026 | 84.89 | 85.17 | 79.77 | 80.61 | 1.41M |
About Celcuity
Celcuity (CELC) is listed on the Nasdaq and classified by the SEC under “Services-Medical Laboratories”. Its business address is in MINNEAPOLIS, MN. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1603454.
CELC board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Richard E Buller | Director | Jun 12, 2026 |
| David Dalvey | Director | Jun 9, 2026 |
| Leo Furcht | Director | Jun 9, 2026 |
| Lance G. Laing | Chief Science Officer | Aug 18, 2026 |
| Polly A. Murphy | Director | Jun 12, 2026 |
| Richard Nigon | Director | Jun 9, 2026 |
| Charles R Romp | Director | Jun 9, 2026 |
| Brian F. Sullivan | Chief Executive Officer | Aug 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Vicky Hahne | Chief Financial Officer | Aug 18, 2026 |
| Lance G. Laing | Chief Science Officer | Aug 18, 2026 |
| Brian F. Sullivan | Chief Executive Officer | Aug 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 14, 2026 | Julian Baker | Sale | 2,838,632 | $102.50 |
| Jul 14, 2026 | Julian Baker | Sale | 261,368 | $102.50 |
| Jul 14, 2026 | Bros. Advisors Lp Baker | Sale | 2,838,632 | $102.50 |
| Jul 14, 2026 | Bros. Advisors Lp Baker | Sale | 261,368 | $102.50 |
| Jul 14, 2026 | Felix Baker | Sale | 2,838,632 | $102.50 |
| Jul 14, 2026 | Felix Baker | Sale | 261,368 | $102.50 |
| Jul 14, 2026 | Bros. Advisors (Gp) Llc Baker | Sale | 2,838,632 | $102.50 |
| Jul 14, 2026 | Bros. Advisors (Gp) Llc Baker | Sale | 261,368 | $102.50 |
| May 4, 2026 | David Dalvey | Sale | 25,000 | $140.68 |
| May 4, 2026 | Richard E Buller | Sale | 2,825 | $142.04 |
| May 4, 2026 | Richard E Buller | Sale | 2,301 | $141.03 |
| May 4, 2026 | Richard E Buller | Sale | 1,670 | $139.58 |
| May 4, 2026 | Richard E Buller | Sale | 550 | $139.00 |
| May 4, 2026 | Richard E Buller | Sale | 1,289 | $137.00 |
| May 4, 2026 | Richard E Buller | Sale | 365 | $143.24 |
CELC financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-177.04M | -3.79 | $-153.28M |
| Dec 31, 2024 | — | $-111.78M | -2.83 | $-83.47M |
| Dec 31, 2023 | — | $-63.78M | -2.69 | $-53.81M |
| Dec 31, 2022 | — | $-40.37M | -2.64 | $-36.01M |
| Dec 31, 2021 | — | $-29.61M | — | $-20.31M |
Latest balance sheet: total assets $828.22M, total liabilities $841.00M, cash $182.05M (as of Jun 30, 2026).
CELC earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 13, 2026 | 8-K Item 2.02 (results) | $86.60 |
| May 14, 2026 | 8-K Item 2.02 (results) | $134.72 |
| Mar 25, 2026 | 8-K Item 2.02 (results) | $110.22 |
| Nov 12, 2025 | 8-K Item 2.02 (results) | $85.15 |
| Aug 14, 2025 | 8-K Item 2.02 (results) | $51.89 |
| May 14, 2025 | 8-K Item 2.02 (results) | $10.86 |
| Mar 31, 2025 | 8-K Item 2.02 (results) | $10.11 |
| Nov 14, 2024 | 8-K Item 2.02 (results) | $14.11 |
| Aug 14, 2024 | 8-K Item 2.02 (results) | — |
| May 15, 2024 | 8-K Item 2.02 (results) | — |
| Mar 27, 2024 | 8-K Item 2.02 (results) | — |
| Nov 13, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Medical Laboratories
Natera (NTRA)Quest Diagnostics (DGX)Guardant Health (GH)Labcorp (LH)Caris Life Sciences (CAI)Grail (GRAL)CareDx (CDNA)Fortrea (FTRE)Veracyte (VCYT)BillionToOne (BLLN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on CELC
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.